Not applicableEnded earlyNCT01346579What this trial is testingBiomarkers in Tissue Samples From Older Women With Breast CancerWho this might be right forBreast Cancer Alliance for Clinical Trials in Oncology 505
Very early researchStudy completedNCT01916122What this trial is testingFluorestradiol (FES) PET/CT for Imaging Estrogen Receptor StatusWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT02455453What this trial is testingAssessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission TomographyWho this might be right forBreast Cancer Washington University School of Medicine 47
Post-approval studies (Phase 4)Study completedNCT00999921What this trial is testingEffects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast CancerWho this might be right forBenign Breast DiseaseFibrocystic Disease of BreastFibroadenoma+1 more Medical College and Hospital Kolkata 256
Not applicableStudy completedNCT02773784What this trial is testingComparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.Who this might be right forInvasive Breast Cancer Peking University 314
Not applicableUnknownNCT04513405What this trial is testingEstrogens Levels and Receptors Status and Skin TearsWho this might be right forSkin TearEstrogen Deficiency University of Catanzaro 1,200
Testing effectiveness (Phase 2)Study completedNCT01625286What this trial is testingInvestigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer PatientsWho this might be right forAdvanced or Metastatic Breast CancerER+ve Advanced or Metastatic Breast Cancer AstraZeneca 148
Testing effectiveness (Phase 2)Ended earlyNCT01616758What this trial is testingPhase II Study of GTx024 in Women With Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer GTx 22
Not applicableUnknownNCT03873428What this trial is testingEvaluation of the Unconformity of the Hormonal Status of Metastatic Lesions During a First Relapse of Breast Cancer Initially Expressing Estrogen Receptors: a Pilot Study on the Interest of PET With FESWho this might be right forFES TEP in Detection of Estrogen Receptors Centre Georges Francois Leclerc 25
Testing effectiveness (Phase 2)Study completedNCT02860000What this trial is testingAlisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast CancerWho this might be right forEstrogen Receptor StatusHER2/Neu NegativeInvasive Breast Carcinoma+6 more Mayo Clinic 96
Large-scale testing (Phase 3)Study completedNCT01986569What this trial is testingDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast CancerWho this might be right forRecurrent Breast CancerStage IV Breast Cancer Asan Medical Center 93
Not applicableLooking for participantsNCT06548919What this trial is testingCurrent Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast CancerWho this might be right forESR1 Gene MutationAdvanced Breast Cancer SciClone Pharmaceuticals 450
Not applicableEnded earlyNCT03619044What this trial is testingThe Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.Who this might be right forHER2-positive Breast Cancer Institut Claudius Regaud 4
Not applicableStudy completedNCT00900133What this trial is testingStudy of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast CancerWho this might be right forBreast Cancer Case Comprehensive Cancer Center 60